Business
China’s EV price war turns into AI arms race beyond cheaper cars
AI signage at the Robert Bosch booth at the Beijing Auto Show in Beijing, China, on Saturday, April 25, 2026. Bloomberg | Bloomberg | Getty Images BEIJING — Electric carmakers in China are layering on more of the same artificial intelligence features as they try to survive a prolonged price war in the world’s largest […]
Read More
Japan Airlines to trial humanoid robots for baggage handling at Haneda airport amid labor crunch
LOS ANGELES, CALIFORNIA – MARCH 7: A Japan Airlines Boeing 787 Dreamliner departs Los Angeles International Airport en route to Tokyo on March 7, 2026 in Los Angeles, California. (Photo by Kevin Carter/Getty Images) Kevin Carter | Getty Images News | Getty Images Japan Airlines has begun testing humanoid robots for ground operations at Tokyo’s Haneda […]
Read More
Reddit’s CEO calls his company ‘the fuel’ for artificial intelligence
Reddit CEO Steve Huffman said his company may be one of the most underappreciated winners of the artificial intelligence boom. “There’s no artificial intelligence without actual intelligence,” he said on “Mad Money.” “The knowledge has to come from somewhere, and Reddit is one of the primary sources for that sort of information that AI’s crave, […]
Read More
Veeva Systems to join S&P 500 index, replacing Coterra Energy
FILE PHOTO: Veeva Systems Founder and CEO Peter Gassner gives an interview on the floor of the New York Stock Exchange. Brendan McDermid | Reuters Veeva Systems, which sells cloud software to life sciences companies and drugmakers, is joining the S&P 500, becoming the latest tech company to get added to the benchmark. The stock […]
Read More
Jim Cramer says the market’s biggest winners all have one thing in common
CNBC’s Jim Cramer said there are essentially only two sectors in the market these days — the data center stocks and everything else. “The data center, the data center, the data center,” said the “Mad Money” host. “You probably tempted to say enough already … but this quarter it went mainstream.” The S&P 500 closed […]
Read More
Rivian renegotiates DOE loan down to $4.5 billion, adjusts capacity plans for Georgia plant
Rivian Automotive on Thursday said it has renegotiated a $6.57 billion loan from the U.S. Department of Energy down to $4.5 billion and is adjusting its production expectations at an under-construction plant in Georgia. The DOE loan was previously set to support two phases of production for a total of 400,000 units annually. The amended […]
Read More
Inside Wealth: Markets are underpricing the risk of Middle East pullback in AI, says tech investor Jack Selby
A potential pullback by Middle East sovereign wealth funds could drain hundreds of billions of dollars from the artificial intelligence boom and threaten key data center projects, according to tech investor Jack Selby. Middle East investors — including sovereign wealth funds and government entities — account for roughly a quarter of global investments committed to […]
Read More
Google cloud growth tops Microsoft and Amazon as all three beat estimates on AI demand
Google Cloud CEO Thomas Kurian speaks at the Google Cloud Next event in San Francisco, April 9, 2019. Michael Short | Bloomberg | Getty Images All three top cloud infrastructure providers surpassed analyst estimates in earnings reports late Wednesday, but Google was the standout, generating its fastest growth rate on record. Google is chasing Amazon […]
Read More
Hershey says GLP-1s are driving higher gum and mint sales
Packages of Ice Breakers spearmint mints Mints are displayed at a Costco Wholesale store on April 27, 2025 in San Diego, California. Kevin Carter | Getty Images Hershey is seeing higher sales for its mints and gum — thanks to the growing use of GLP-1 drugs. “We’ve also seen strong demand for gum and mints, […]
Read More
FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list in win for the companies
The headquarters of the U.S. Food and Drug Administration in Silver Spring, Maryland, Nov. 4, 2009. Jason Reed | Reuters The Food and Drug Administration on Thursday proposed excluding the active ingredients in Novo Nordisk and Eli Lilly‘s blockbuster obesity and diabetes medications from the list of drugs that outsourcing facilities can use for compounding […]
Read More